Traveller’s diarrhoea
Clinical studies show strong evidence that children and adults with acute gastroenteritis caused by various causative agents while traveling benefit from the administration of BioGaia ProTectis.
Traveler's diarrhoea is the most common illness affecting travelers. An estimated 10 million people – 20% to 50% of international travelers – develop it annually.
It is defined as three or more unformed stools in 24 hours passed by a traveler, commonly accompanied by abdominal cramps, nausea, and bloating. The primary source of infection is ingestion of fecally contaminated food or water.
Several systematic reviews have found probiotics to be effective in reducing the duration of diarrhoea in children and adults.
Amongst those Shornikova showed that after 2days of treatment with BioGaia 74 % of the patients have been free from watery diarrhoea and vomiting - published 1997 in the medical journal J. Pediatr. Gastroenterol. Nutr. Also the study from Francavilla published in 2012 showed the efficacy and safety of BioGaia Protectis while treating children with acute watery diarrhoea.
Containing Limosilactobacillus reuteri Protectis, BioGaia Pobiotic Drops and Tablets promote the growth of good bacteria in the intestinal tract, re-establishing a healthy bacterial balance and thus significantly reduce the duration of watery diarrhoea and even increase the resistance.
Limosilactobacillus reuteri as a therapeutic agent in acute diarrhoea in young children.
Shornikova AV et al. J. Pediatr. Gastroenterol. Nutr. 1997;24:399-404.
Significant faster recovery from watery diarrhoea in hospitalised children supplemented with Limosilactobacillus reuteri Protectis.
Limosilactobacillus reuteri DSM 17938 vs placebo in children with acute diarrhoea.
Francavilla R et al. (2012) Randomised clinical trial: Aliment Pharmacol Ther. 36: 363-369.